Published by Josh White on 30th September 2021
(Sharecast News) - Clinical-stage biopharmaceutical company Avacta Group reported cash and short-term deposits of £37m at the end of its first half on Thursday, down from £54.5m a year ago and £47.9m at the start of the period.
URL: http://www.digitallook.com/dl/news/story/32158935/...